<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Briefs</title>
    <description>
      <![CDATA[]]>
    </description>
    <link>https://www.bioworld.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Biopharma money raised: Jan. 1-April 16, 2026</title>
      <description>
        <![CDATA[Year-to-date money raised in public, private and other financings of biopharma companies.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730511</guid>
      <pubDate>Fri, 17 Apr 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730511-biopharma-money-raised-jan-1-april-16-2026</link>
    </item>
    <item>
      <title>Money raised by biopharma</title>
      <description>
        <![CDATA[Total raised in public, private and other financings of biopharma companies, comparing 2019-2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730510</guid>
      <pubDate>Fri, 17 Apr 2026 13:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730510-money-raised-by-biopharma</link>
    </item>
    <item>
      <title>Regulatory actions for April 17, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adimab, Aicuris, Bavarian Nordic, Cumberland, Fertilai, Grifols, Mabwell, Medera, Royal Philips, Savara, Surgentec, Waiv.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730415</guid>
      <pubDate>Fri, 17 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730415-regulatory-actions-for-april-17-2026</link>
    </item>
    <item>
      <title>Other news to note for April 17, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Aligos, Amgen, Amoytop, Astellas, Caredx, Cathether, Daiichi, Eurobio, Interna, Johnson & Johnson, Mabwell, Meiragtx, Sanofi, Vir.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730414</guid>
      <pubDate>Fri, 17 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730414-other-news-to-note-for-april-17-2026</link>
    </item>
    <item>
      <title>In the clinic for April 17, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Acerand, Axena, Boehringer Ingelheim, Bold, Eli Lilly, Freya, Xvivo.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730413</guid>
      <pubDate>Fri, 17 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730413-in-the-clinic-for-april-17-2026</link>
    </item>
    <item>
      <title>Financings for April 17, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Achieve Life Sciences, Acurx, Adlai, Meiragtx, Onward, Pamdx.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730412</guid>
      <pubDate>Fri, 17 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730412-financings-for-april-17-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 17, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Achieve Life Sciences, Aktis, Araceli, Assureckd, Cubit, Envoy, Eton, Greywolf, Harbour, Helus, Juvisé, Neutrolis, Prime, Xilo.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730411</guid>
      <pubDate>Fri, 17 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730411-appointments-and-advancements-for-april-17-2026</link>
    </item>
    <item>
      <title>Today's news in brief</title>
      <description>
        <![CDATA[BioWorld briefs for April 17, 2026.]]>
      </description>
      <guid>http://www.bioworld.com/articles/432891</guid>
      <pubDate>Fri, 17 Apr 2026 10:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/432891-todays-news-in-brief</link>
    </item>
    <item>
      <title>Regulatory actions for April 16, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Airs, Aligos, AOP, Arbutus, ARS, Cala, C-mo, Dogwood, Immutep, Leadiant, Leo, Northstar, Opna, Partner, Reach Surgical, Waters, Xspray.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730401</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730401-regulatory-actions-for-april-16-2026</link>
    </item>
    <item>
      <title>Other news to note for April 16, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: 35Pharma, Accurkardia, Acuitas, Adia, Cepheid, Circio, Daiichi, GSK, Olea, Ovation, Oxford Nanopore, Oxipit, Precisionlife, QT Imaging, Robocath, Sectra, Specialized Medical, Stereotaxis, Wayfinder.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730400</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730400-other-news-to-note-for-april-16-2026</link>
    </item>
    <item>
      <title>In the clinic for April 16, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Aligos, Brenus, Clearmind, Cosmo, Orvida, PDS, Tensive, Tonix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730399</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730399-in-the-clinic-for-april-16-2026</link>
    </item>
    <item>
      <title>Financings for April 16, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Allogene, Beeline, Heartbeam, Sonire, Telix, Terremoto, Traws, Verismo.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730398</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730398-financings-for-april-16-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 16, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Aerska, Caristo, Enodia, Enveda, Evotec, Kazia, Lamassu, Minervax, Neuraclick, Noxopharm, Oryon, OSE, Plus, Prelude, Structure, Tango, Zealand.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730397</guid>
      <pubDate>Thu, 16 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730397-appointments-and-advancements-for-april-16-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 15, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Grace, Holling, Ligand, Nxera, Praxis, Protaryx, Radical Catheter, Renaissance, Toby, Travere.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730320</guid>
      <pubDate>Wed, 15 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730320-regulatory-actions-for-april-15-2026</link>
    </item>
    <item>
      <title>Other news to note for April 15, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: 4D Path, Bioaffinity, Bostongene, Crossbridge, Daiichi, Eli Lilly, Immunogenesis, Harbinger, Kazia, Neurocrine, Novo Nordisk, Vasa, Vectus, Xortx.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730319</guid>
      <pubDate>Wed, 15 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730319-other-news-to-note-for-april-15-2026</link>
    </item>
    <item>
      <title>In the clinic for April 15, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Actuate, Alkermes, Antiva, Biotronik, Clearmind, Kelun-Biotech, Kiora, Penumbra, Renovorx, Sirtex.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730318</guid>
      <pubDate>Wed, 15 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730318-in-the-clinic-for-april-15-2026</link>
    </item>
    <item>
      <title>Financings for April 15, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Adcendo, Advanced Bionics, Alamar, Galera, Kailera, Obsidian, Senhwa, Spiral.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730317</guid>
      <pubDate>Wed, 15 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730317-financings-for-april-15-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 15, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Adagene, Asgard, Harmony, Inspira, Kashiv, Kivu, Laigo, Panntherapi, Parabilis, Tempest, Valanx, Valo.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730316</guid>
      <pubDate>Wed, 15 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730316-appointments-and-advancements-for-april-15-2026</link>
    </item>
    <item>
      <title>In the clinic for April 14, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech, including data readouts and publications: Abbvie, Allogene, Biontech, Caliway, Caliway, Corcept, Duality, Eli Lilly, Genmab, GSK, Ideaya, Impact, Lixte, Ocular, Pharmasens, Revolution, Servier, Spyre, Synox.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730307</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730307-in-the-clinic-for-april-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 14, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Beckman Coulter Diagnostics, Daiichi, Kymera, Merck, Prosomnus, Regeneron, Replimune, Roche, Sanofi.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730305</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730305-regulatory-actions-for-april-14-2026</link>
    </item>
    <item>
      <title>Other news to note for April 14, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Abbvie, Collplant.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730304</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730304-other-news-to-note-for-april-14-2026</link>
    </item>
    <item>
      <title>Financings for April 14, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies raising money in public or private financings, including: Hemab, Imagenebio, Lobe, Neomorph, Quiver, Seaport, Sharp.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730302</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730302-financings-for-april-14-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 14, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries, including: Alx Oncology, Dariohealth, Epitopea, Frontier, Geron, Leal, Lineage, Nrx, OS, Palvella, Pelthos, Prothena.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730301</guid>
      <pubDate>Tue, 14 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730301-appointments-and-advancements-for-april-14-2026</link>
    </item>
    <item>
      <title>Regulatory actions for April 14, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech in Asia-Pacific, including global submissions and approvals, and other regulatory decisions and designations: Duality, GSK, Lynk, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730368</guid>
      <pubDate>Tue, 14 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730368-regulatory-actions-for-april-14-2026</link>
    </item>
    <item>
      <title>Other news to note for April 14, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech happenings in Asia-Pacific, including deals and partnerships, and other news in brief: Amgen, Astellas, Biocon, Cartherics, Catalent, Daiichi Sankyo, Denali, Dyno, Eli Lilly, Gan & Lee, Imagene AI, JW, Nxera, Takeda.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730367</guid>
      <pubDate>Tue, 14 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730367-other-news-to-note-for-april-14-2026</link>
    </item>
    <item>
      <title>In the clinic for April 14, 2026</title>
      <description>
        <![CDATA[Clinical updates for biopharma and med tech in Asia-Pacific, including data readouts and publications: Akeso, Alar, Leads, Radiopharm.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730366</guid>
      <pubDate>Tue, 14 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730366-in-the-clinic-for-april-14-2026</link>
    </item>
    <item>
      <title>Financings for April 14, 2026</title>
      <description>
        <![CDATA[Biopharma and med-tech companies in Asia-Pacific raising money in public or private financings: OS Therapies, Syneron.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730365</guid>
      <pubDate>Tue, 14 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730365-financings-for-april-14-2026</link>
    </item>
    <item>
      <title>Appointments and advancements for April 14, 2026</title>
      <description>
        <![CDATA[New hires and promotions in the biopharma and med-tech industries in Asia-Pacific, including: Ailux, Aravax, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730364</guid>
      <pubDate>Tue, 14 Apr 2026 08:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730364-appointments-and-advancements-for-april-14-2026</link>
    </item>
    <item>
      <title>News in brief</title>
      <description>
        <![CDATA[BioWorld Asia briefs for April 14, 2026]]>
      </description>
      <guid>http://www.bioworld.com/articles/435994</guid>
      <pubDate>Tue, 14 Apr 2026 01:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/435994-news-in-brief</link>
    </item>
    <item>
      <title>Regulatory actions for April 13, 2026</title>
      <description>
        <![CDATA[Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Apotex, Boxspine, Difgen, Duality Biologics, GSK, Lynk, Medcad, Sibel, Sobi, Telix.]]>
      </description>
      <guid>http://www.bioworld.com/articles/730291</guid>
      <pubDate>Mon, 13 Apr 2026 12:00:00 -0400</pubDate>
      <link>https://www.bioworld.com/articles/730291-regulatory-actions-for-april-13-2026</link>
    </item>
  </channel>
</rss>
